Taking Wegovy at Night? Why Timing Can Make or Break Your Results
Weight loss meds like GLP-1s have changed the game for so many people. For a long time, if you…
-
-
Oral Semaglutide & Levothyroxine: Key Facts
Oral semaglutide (often prescribed as Rybelsus) has made a big difference in how we manage weight loss and diabetes….
-
First Weight-Loss Pill Gets the Green Light
For years, the most effective weight-loss drugs came with a catch: you had to inject them. That’s changing. Regulators…
-
Novo Nordisk Takes an Early Lead in the Weight Loss Pill Race
Novo Nordisk got greenlit by the Food and Drug Administration for its daily semaglutide pill in December 2025. This…
-
Novo Nordisk Oral Wegovy Strengthens Obesity Market
Novo Nordisk recorded over three million prescriptions for oral Wegovy within five months of its availability. Financial analysts gave…
-
Novo Nordisk to Seek Chinese Approval for Wegovy Pill Amid Rising Competition
Novo Nordisk plans to seek approval for its oral weight loss medication. The company will soon submit applications to…
-
The New GLP-1 Pill: What High Performers Need to Know
The arrival of oral GLP-1 pills marks a massive change in how we treat obesity and type 2 diabetes….
-
Novo and Lilly Intensify Competition in the GLP-1 Pill Market Ahead of Medicare Reform
Novo Nordisk and Eli Lilly are advancing competing oral GLP-1 receptor agonist programs as a landmark federal policy shift…
-
Novo Nordisk’s Wegovy Pill Gains Momentum, but Eli Lilly Sees Lead Intact
The weight loss drug market is moving faster than ever, and the competition among major pharmaceutical companies continues to…
-
Eli Lilly’s Retatrutide Achieves Bariatric-Level Weight Loss in Phase III Trial
Researchers recently shared exciting news from a major clinical study called TRIUMPH-1. This trial looked at how a new…
